| Role |
Name |
Disclosure |
Details |
| Author | Edward A DiPreta, MD, Department of Dermatology, Dermatology & Skin Cancer Center of Georgia | novartis | Details | | Coauthor | Kurt Maggio, MD, Director of Dermatologic Surgery and Cutaneous Oncology, Assistant Chief, Department of Dermatology, Walter Reed Army Medical Center | Nothing to disclose | Details | | Medical Editor | Mark W Cobb, MD, Consulting Staff, WNC Dermatological Associates | Nothing to disclose | Details | | Pharmacy Editor | Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Managing Editor | Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory | Nothing to disclose | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Kurt Maggio, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Mark W Cobb, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Joel M Gelfand, CME Editor |
The contributor discloses no conflict of interest. |
|